Antigenic peptide derived from T790M point mutation sequence of epidermal growth factor receptor

摘要

The present application relates to an antigen peptide derived from the sequence of epidermal growth factor receptor having T790M point mutation and a pharmaceutical composition for the treatment of cancer comprising the peptide.